Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020091312 - COMPOSITION FOR PREVENTING OR TREATING ALCOHOLIC INTESTINAL INJURY, CONTAINING PROBIOTICS AS ACTIVE INGREDIENT

Publication Number WO/2020/091312
Publication Date 07.05.2020
International Application No. PCT/KR2019/014095
International Filing Date 24.10.2019
IPC
A61K 35/747
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A61K 35/745
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
745Bifidobacteria
A61P 1/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC
A61K 35/745
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
745Bifidobacteria
A61K 35/747
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
Applicants
  • 주식회사 종근당바이오 CKD BIO CORP [KR]/[KR]
Inventors
  • 박나현 PARK, Nahyun
  • 김우리 KIM, Woo Ri
  • 이인옥 LEE, Inock
  • 김병국 KIM, Byoung-Kook
  • 최인석 CHOI, In Suk
Agents
  • 윤대웅 YOON, Dae Woong
Priority Data
10-2018-013120830.10.2018KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) COMPOSITION FOR PREVENTING OR TREATING ALCOHOLIC INTESTINAL INJURY, CONTAINING PROBIOTICS AS ACTIVE INGREDIENT
(FR) COMPOSITION CONTENANT DES PROBIOTIQUES EN TANT QUE PRINCIPE ACTIF POUR PRÉVENIR OU TRAITER DES LÉSIONS INTESTINALES CAUSÉES PAR LA CONSOMMATION D'ALCOOL
(KO) 프로바이오틱스를 유효성분으로 포함하는 알코올성 장손상 예방 또는 치료용 조성물
Abstract
(EN)
The present invention pertains to a composition for preventing or treating alcoholic intestinal injury, the composition containing probiotics as an active ingredient. The composition of the present invention contains Lactobacillus bulgaricus CKDB001 (Accession Number: KCTC13669B), Lactobacillus helveticus CKDB001 (Accession Number: KCTC13670BP), Lactobacillus plantarum CKDB008 (Accession Number: KCTC13673BP), or Bifidobacterium bifidum CKDB001 (Accession Number: KCTC13114BP), which are novel isolated lactic acid strains, or a mixed strain thereof, has an excellent effect of reducing intestinal cell inflammation caused by alcoholic irritation, and can thus be usefully used as food or a therapeutic agent for preventing or alleviating alcoholic intestinal injury.
(FR)
La présente invention concerne une composition pour prévenir ou traiter des lésions intestinales causées par la consommation d'alcool, ladite composition contenant des probiotiques en tant que principe actif. La composition de la présente invention contient Lactobacillus bulgaricus CKDB001 (Numéro d'entrée: KCTC13669B), Lactobacillus helveticus CKDB001 (Numéro d'entrée: KCTC13670BP), Lactobacillus plantarum CKDB008 (Numéro d'entrée: KCTC13673BP), ou Bifidobacterium bifidum CKDB001 (Numéro d'entrée: KCTC13114BP), qui sont de nouvelles souches d'acide lactique isolées, ou une souche mélangée de celles-ci, ont un excellent effet de réduction de l'inflammation des cellules intestinales provoquée par une irritation causée par la consommation d'alcool, et peuvent ainsi avoir une utilisation utile en tant qu'aliment ou agent thérapeutique pour prévenir ou soulager une lésion intestinale causée par la consommation d'alcool.
(KO)
본 발명은 프로바이오틱스를 유효성분으로 포함하는 알코올성 장손상 예방 또는 치료용 조성물에 관한 것이다. 본 발명의 조성물은 신규 분리 유산균주인 락토바실러스 불가리쿠스(Lactobacillus bulgaricus) CKDB001 (수탁번호: KCTC13669B), 락토바실러스 헬베티쿠스(Lactobacillus helveticus) CKDB001 (수탁번호: KCTC13670BP), 락토바실러스 플란타럼(Lactobacillus plantarum) CKDB008 (수탁번호: KCTC13673BP), 비피도박테리움 비피덤(Bifidobacterium bifidum) CKDB001 (수탁번호 KCTC13114BP), 또는 이들의 혼합 균주를 포함하며, 알코올 자극으로 인한 장내 세포의 염증 감소 효과가 우수하므로 알코올성 장손상을 예방, 개선하기 위한 식품 또는 치료제로 유용하게 사용될 수 있다.
Also published as
Latest bibliographic data on file with the International Bureau